Requiring price disclosures on advertisements for prescription drugs would empower patients and reduce excess spending on ...
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.
Trump dismissed the order as part of what he called Biden’s “unpopular, inflationary, illegal, and radical practices.” ...
Rising pharmaceutical costs and skimpy insurance coverage can mean larger medication bills for US consumers. But clinicians ...
Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...
The majority of Americans think prescription drug costs are unreasonable and believe a major contributor to the high cost is profits made by pharmaceutical companies, a survey by KFF found.
Bracing for a federal funding drought and higher state costs for Medicare and Medicaid, Gov. Ned Lamont urged pharma ...
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of ...
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback